REFERENCES
- Cushing T, Clericuzio C L, Wilson C S, Taub J W, Ge Y, Reichard K K, Winter S S. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder. J Pediatr 2006; 148: 687–689
- Al-Kasim F, Doyle J J, Massey G V, Weinstein H J, Zipursky A. Pediatric Oncology Group. Incidence and treatment of potentially lethal diseases in transient leukemia of down syndrome:Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2002; 24: 9–13
- Hongeng S, Pakakasama S, Hathirat P, Phuapradid P, Worapongpaiboon S. Diffuse hepatic fibrosis with transient myeloproliferative disorders in down syndrome. J Pediatr Hematol Oncol 2000; 22: 543–544
- Trizzino A, Farruggia P, Russo D, D'Angelo P, Tropia S, Benigno V, Tarantino G, Di Marco V, Arico M. Congenital hepatic fibrosis: a very uncommon cause of pancytopenia in children. J Pediatr Hematol Oncol 2005; 27: 567–568
- Brink D S. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of down syndrome. Adv Anat Pathol 2006; 13: 256–262
- Holt S E, Brown E J, Zipursky A. Telomerase and the benign and malignant megakaryoblastic leukemias of down syndrome. J Pediatr Hematol Oncol 2002; 24: 14–17
- Marino B. Congenital heart disease in patients with down's syndrome: anatomic and genetic aspects. Biomed Pharmacother 1993; 47: 197–200
- Azancot A, Diehl R, Dorgeret S, Sebag G, Baumann C, Vuillard E, Machado L, Luton D, Oury J F. Isolated pericardial effusion in the human fetus: a report of three cases. Prenat Diagn 2003; 23: 193–197
- Oetama B K, Tucay R F, Morgan D L. Pathologic quiz case: nonimmune hydrops in a newborn. Down syndrome with acute (transient) leukemia. Arch Pathol Lab Med 2001; 125: 1609–1610